Literature DB >> 21108935

Knockdown of the DNA-dependent protein kinase catalytic subunit radiosensitizes glioma-initiating cells by inducing autophagy.

Wenzhuo Zhuang1, Bingzong Li, Linmei Long, Liesong Chen, Qiang Huang, Zhong-Qin Liang.   

Abstract

Glioblastoma (GBM) is a highly aggressive brain tumor characterized by increased proliferation and resistance to chemotherapy and radiotherapy. A growing body of evidence suggests that only a small subpopulation of malignant glioma cells, called glioma stem cells or glioma-initiating cells (GICs), have true tumorigenic potential and confer glioma radioresistance. DNA-dependent protein kinase catalytic subunit (DNA-PKcs) plays a major role in the repair of DNA double-strand breaks induced by ionizing radiation (IR). Suppression of one of these components of the DNA-PK complex can inhibit the DNA double-strand break repair and radiosensitize the cells. In general, the cell death induced by IR is considered to be apoptotic. Recently, autophagy, an alternative form of programmed cell death, has been shown to contribute significantly to anti-neoplastic effects of radiation therapy. Autophagy is independent of phagocytes and differs from apoptosis by the presence of autophagosomes, autolysosomes, and an intact nucleus in the cell. Little is known, however, regarding the relationship between DNA-PKcs and IR-induced autophagy in GICs. In the present study, we constructed plasmids encoding short hairpin RNA (shRNA) targeting DNA-PKcs, which were then transfected into GICs. Then, we used GICs and DNA-PKcs-RNAi transfected cells to investigate the role of DNA-PKcs in IR-induced apoptotic and autophagic cell death. IR induced massive autophagic cell death in DNA-PKcs-RNAi transfected cells, but only occasional apoptotic cells were detected among GICs. Specific inhibition of DNA-PKcs in GICs induced autophagy and radiosensitized the cells. Our results suggest that such radiation-induced autophagy may enhance the effect of glioma therapies. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21108935     DOI: 10.1016/j.brainres.2010.11.044

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

Review 1.  Genotypic characteristics of resistant tumors to pre-operative ionizing radiation in rectal cancer.

Authors:  Zeeshan Ramzan; Ammar B Nassri; Sergio Huerta
Journal:  World J Gastrointest Oncol       Date:  2014-07-15

2.  Musashi1 Impacts Radio-Resistance in Glioblastoma by Controlling DNA-Protein Kinase Catalytic Subunit.

Authors:  Patricia Rosa de Araujo; Aparna Gorthi; Acarizia E da Silva; Sonal S Tonapi; Dat T Vo; Suzanne C Burns; Mei Qiao; Philip J Uren; Zhi-Min Yuan; Alexander J R Bishop; Luiz O F Penalva
Journal:  Am J Pathol       Date:  2016-07-25       Impact factor: 4.307

3.  MIR137 Regulates Starvation-Induced Autophagy by Targeting ATG7.

Authors:  Yuecheng Zeng; Gang Huo; Yongbiao Mo; Wentao Wang; Hong Chen
Journal:  J Mol Neurosci       Date:  2015-02-17       Impact factor: 3.444

Review 4.  Role of autophagy in regulating the radiosensitivity of tumor cells.

Authors:  Yong Xin; Fan Jiang; Chunsheng Yang; Qiuyue Yan; Wenwen Guo; Qian Huang; Longzhen Zhang; Guan Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-07       Impact factor: 4.553

Review 5.  Cancer stem cells and chemoresistance: The smartest survives the raid.

Authors:  Jihe Zhao
Journal:  Pharmacol Ther       Date:  2016-02-17       Impact factor: 12.310

Review 6.  The interplay between DNA repair and autophagy in cancer therapy.

Authors:  Dan Zhang; Bo Tang; Xia Xie; Yu-Feng Xiao; Shi-Ming Yang; Jian-Wei Zhang
Journal:  Cancer Biol Ther       Date:  2015-05-18       Impact factor: 4.742

Review 7.  Differential regulatory functions of three classes of phosphatidylinositol and phosphoinositide 3-kinases in autophagy.

Authors:  Xinlei Yu; Yun Chau Long; Han-Ming Shen
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

8.  NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro.

Authors:  Wen-juan Wang; Lin-mei Long; Neng Yang; Qing-qing Zhang; Wen-jun Ji; Jiang-hu Zhao; Zheng-hong Qin; Zhong Wang; Gang Chen; Zhong-qin Liang
Journal:  Acta Pharmacol Sin       Date:  2013-04-22       Impact factor: 6.150

9.  Temporal DNA-PK activation drives genomic instability and therapy resistance in glioma stem cells.

Authors:  Yanling Wang; Haineng Xu; Tianrun Liu; Menggui Huang; Param-Puneet Butter; Chunsheng Li; Lin Zhang; Gary D Kao; Yanqing Gong; Amit Maity; Constantinos Koumenis; Yi Fan
Journal:  JCI Insight       Date:  2018-02-08

10.  Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment.

Authors:  Feng-Ming Hsu; Shichuan Zhang; Benjamin P C Chen
Journal:  Transl Cancer Res       Date:  2012-05-22       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.